Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JUAN FUEYO-MARGARETO and CANDELARIA GOMEZ-MANZANO.
JUAN FUEYO-MARGARETO
Connection Strength
5.388
CANDELARIA GOMEZ-MANZANO
  1. Gene therapy. Handb Clin Neurol. 2012; 104:331-8.
    View in: PubMed
    Score: 0.420
  2. Oncolytic adenoviruses for the treatment of brain tumors. Curr Opin Mol Ther. 2010 Oct; 12(5):530-7.
    View in: PubMed
    Score: 0.385
  3. Interspecies adenovirus fiber shows "evolutionary" advantage for oncolytic therapy of gliomas. Cancer Biol Ther. 2008 May; 7(5):794-6.
    View in: PubMed
    Score: 0.326
  4. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clin Cancer Res. 2006 Jan 15; 12(2):556-62.
    View in: PubMed
    Score: 0.278
  5. Genetically modified adenoviruses against gliomas: from bench to bedside. Neurology. 2004 Aug 10; 63(3):418-26.
    View in: PubMed
    Score: 0.252
  6. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene. 2004 Mar 11; 23(10):1821-8.
    View in: PubMed
    Score: 0.245
  7. [Molecular control of the cellular cycle and apoptosis: new treatments for gliomas]. Neurologia. 1998 Aug-Sep; 13(7):349-55.
    View in: PubMed
    Score: 0.166
  8. Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. Cancer Res. 2017 07 15; 77(14):3894-3907.
    View in: PubMed
    Score: 0.153
  9. Intratumoral heterogeneity and intraclonal plasticity: from warburg to oxygen and back again. Neuro Oncol. 2014 Aug; 16(8):1025-6.
    View in: PubMed
    Score: 0.125
  10. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PLoS One. 2014; 9(5):e97407.
    View in: PubMed
    Score: 0.124
  11. Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget. 2014 Apr 30; 5(8):2208-20.
    View in: PubMed
    Score: 0.124
  12. Targeting brain tumor stem cells with oncolytic adenoviruses. Methods Mol Biol. 2012; 797:111-25.
    View in: PubMed
    Score: 0.105
  13. The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells. PLoS One. 2011; 6(12):e29467.
    View in: PubMed
    Score: 0.105
  14. Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype. Oncotarget. 2010 Dec; 1(8):700-9.
    View in: PubMed
    Score: 0.097
  15. [Wernicke's encephalopathy in a female patient with the acquired immunodeficiency syndrome]. Med Clin (Barc). 1990 Dec 01; 95(19):754-5.
    View in: PubMed
    Score: 0.097
  16. RB-E2F1: molecular rheostat for autophagy and apoptosis. Autophagy. 2010 Nov; 6(8):1216-7.
    View in: PubMed
    Score: 0.097
  17. Advances in translational research in neuro-oncology. Arch Neurol. 2011 Mar; 68(3):303-8.
    View in: PubMed
    Score: 0.097
  18. The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010 Oct 15; 70(20):7882-93.
    View in: PubMed
    Score: 0.096
  19. [Internuclear ophthalmoplegia related to opiate overdose]. Med Clin (Barc). 1990 Apr 28; 94(16):637.
    View in: PubMed
    Score: 0.094
  20. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther. 2009 Oct; 9(5):422-7.
    View in: PubMed
    Score: 0.090
  21. Autophagy pathways in glioblastoma. Methods Enzymol. 2009; 453:273-86.
    View in: PubMed
    Score: 0.085
  22. VEGF Trap induces antiglioma effect at different stages of disease. Neuro Oncol. 2008 Dec; 10(6):940-5.
    View in: PubMed
    Score: 0.083
  23. E2F1 in gliomas: a paradigm of oncogene addiction. Cancer Lett. 2008 May 18; 263(2):157-63.
    View in: PubMed
    Score: 0.081
  24. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther. 2008 Mar; 16(3):487-93.
    View in: PubMed
    Score: 0.080
  25. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res. 2007 Dec 15; 67(24):11499-504.
    View in: PubMed
    Score: 0.079
  26. Adenovirus's last trick: you say lysis, we say autophagy. Autophagy. 2008 Jan; 4(1):118-20.
    View in: PubMed
    Score: 0.079
  27. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
    View in: PubMed
    Score: 0.078
  28. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res. 2007 Sep 01; 67(17):8255-63.
    View in: PubMed
    Score: 0.078
  29. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9.
    View in: PubMed
    Score: 0.076
  30. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res. 2006 Dec; 4(12):915-26.
    View in: PubMed
    Score: 0.074
  31. Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas. Expert Rev Anticancer Ther. 2006 Nov; 6(11):1585-92.
    View in: PubMed
    Score: 0.073
  32. A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation. FASEB J. 2006 Dec; 20(14):2603-5.
    View in: PubMed
    Score: 0.073
  33. E2F1 and telomerase: alliance in the dark side. Cell Cycle. 2006 May; 5(9):930-5.
    View in: PubMed
    Score: 0.071
  34. Oncolytic adenoviruses as antiglioma agents. Expert Rev Anticancer Ther. 2006 May; 6(5):697-708.
    View in: PubMed
    Score: 0.071
  35. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28.
    View in: PubMed
    Score: 0.071
  36. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
    View in: PubMed
    Score: 0.069
  37. Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses. Neoplasia. 2005 Aug; 7(8):723-9.
    View in: PubMed
    Score: 0.067
  38. Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94.
    View in: PubMed
    Score: 0.065
  39. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas. Neoplasia. 2005 Jan; 7(1):48-56.
    View in: PubMed
    Score: 0.065
  40. Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma. Cancer Gene Ther. 2004 Nov; 11(11):713-20.
    View in: PubMed
    Score: 0.064
  41. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60.
    View in: PubMed
    Score: 0.058
  42. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol. 2003 Jan; 53(1):109-17.
    View in: PubMed
    Score: 0.056
  43. Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells. Int J Oncol. 2002 Nov; 21(5):1015-20.
    View in: PubMed
    Score: 0.056
  44. [Oncolytic adenovirus for the treatment of cerebral tumors: past, present and future]. Neurologia. 2001 Mar; 16(3):122-7.
    View in: PubMed
    Score: 0.050
  45. Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells. IEEE Trans Nanobioscience. 2015 Dec; 14(8):946-51.
    View in: PubMed
    Score: 0.034
  46. The oncolytic adenovirus ?24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity. J Bone Miner Res. 2014 Oct; 29(10):2287-96.
    View in: PubMed
    Score: 0.032
  47. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.027
  48. [Paraneoplastic encephalomyelitis and Lambert-Eaton syndrome]. Rev Neurol (Paris). 1992; 148(10):605-9.
    View in: PubMed
    Score: 0.026
  49. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One. 2011; 6(11):e26740.
    View in: PubMed
    Score: 0.026
  50. [Bezafibrate-induced necrotizing myopathy]. Med Clin (Barc). 1991 Mar 23; 96(11):439.
    View in: PubMed
    Score: 0.025
  51. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol. 2011 May; 85(10):4720-9.
    View in: PubMed
    Score: 0.025
  52. Oncolytic adenoviruses for malignant glioma therapy. Front Biosci. 2003 May 01; 8:d577-88.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.